ENTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Entera Bio Ltd.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$2.94+0.26 (+9.70%)
Close on Oct 19, 2026
- Market cap
- $148.33M
- P/E (TTM)
- 11.8
- Dividend yield
- –
Community
Notes and questions about Entera Bio from other investors
No posts about ENTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.